Pacer Advisors, Inc. - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 211 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 3.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Pacer Advisors, Inc. ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$8,354
-99.9%
303
-99.9%
0.00%
-100.0%
Q2 2023$13,496,790
+36.5%
448,995
+62.0%
0.05%
+5.9%
Q4 2022$9,886,618
+308.0%
277,169
+205.0%
0.05%
+64.5%
Q3 2021$2,423,000
-18.1%
90,866
-5.4%
0.03%
-26.2%
Q2 2021$2,957,000
+103.5%
96,034
+73.0%
0.04%
+68.0%
Q1 2021$1,453,000
+212.5%
55,516
+200.1%
0.02%
+177.8%
Q4 2020$465,000
+44.9%
18,500
+20.0%
0.01%
+28.6%
Q3 2020$321,000
+68.9%
15,423
+92.4%
0.01%
+75.0%
Q2 2020$190,000
-5.5%
8,017
-20.6%
0.00%0.0%
Q1 2020$201,000
-59.4%
10,100
-51.6%
0.00%
-81.8%
Q4 2019$495,000
-22.7%
20,851
-10.5%
0.02%
+57.1%
Q3 2019$640,000
+18.7%
23,303
+43.0%
0.01%
+7.7%
Q2 2019$539,000
+9.3%
16,298
+15.9%
0.01%
-7.1%
Q1 2019$493,000
+24.2%
14,058
+17.5%
0.01%0.0%
Q4 2018$397,00011,9600.01%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders